Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys.

Veazey RS, Acierno PM, McEvers KJ, Baumeister SH, Foster GJ, Rett MD, Newberg MH, Kuroda MJ, Williams K, Kim EY, Wolinsky SM, Rieber EP, Piatak M Jr, Lifson JD, Montefiori DC, Brown CR, Hirsch VM, Schmitz JE.

J Virol. 2008 Jun;82(11):5618-30. doi: 10.1128/JVI.02748-07. Epub 2008 Mar 26.

2.

Contribution of CD8+ T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in Simian immunodeficiency virus-infected rhesus monkeys.

Kim EY, Veazey RS, Zahn R, McEvers KJ, Baumeister SH, Foster GJ, Rett MD, Newberg MH, Kuroda MJ, Rieber EP, Piatak M Jr, Lifson JD, Letvin NL, Wolinsky SM, Schmitz JE.

J Virol. 2008 Jun;82(11):5631-5. doi: 10.1128/JVI.02749-07. Epub 2008 Mar 26.

3.

Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys.

Acierno PM, Schmitz JE, Gorgone DA, Sun Y, Santra S, Seaman MS, Newberg MH, Mascola JR, Nabel GJ, Panicali D, Letvin NL.

J Immunol. 2006 May 1;176(9):5338-45.

4.

Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.

Newberg MH, McEvers KJ, Gorgone DA, Lifton MA, Baumeister SH, Veazey RS, Schmitz JE, Letvin NL.

J Immunol. 2006 Jan 1;176(1):319-28.

5.

Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys.

Seaman MS, Santra S, Newberg MH, Philippon V, Manson K, Xu L, Gelman RS, Panicali D, Mascola JR, Nabel GJ, Letvin NL.

J Virol. 2005 Apr;79(8):4580-8.

6.

Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.

Peyerl FW, Bazick HS, Newberg MH, Barouch DH, Sodroski J, Letvin NL.

J Virol. 2004 Dec;78(24):13901-10.

7.

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J.

J Immunol. 2004 May 15;172(10):6290-7.

8.

A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.

Newberg MH, Kuroda MJ, Charini WA, Miura A, Lord CI, Schmitz JE, Gorgone DA, Lifton MA, Kuus-Reichel K, Letvin NL.

Virology. 2002 Sep 30;301(2):365-73.

10.

Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen.

Schumacher IK, Newberg MH, Jackson JD, Hammel JM, Rubocki RJ, Engelhard VH, Fox IJ.

Transplantation. 1996 Sep 27;62(6):831-6.

PMID:
8824485
11.

Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.

Newberg MH, Smith DH, Haertel SB, Vining DR, Lacy E, Engelhard VH.

J Immunol. 1996 Apr 1;156(7):2473-80.

PMID:
8786307
12.

Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice.

Man S, Newberg MH, Crotzer VL, Luckey CJ, Williams NS, Chen Y, Huczko EL, Ridge JP, Engelhard VH.

Int Immunol. 1995 Apr;7(4):597-605.

PMID:
7547687
13.

Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.

Smith DM, Bluestone JA, Jeyarajah DR, Newberg MH, Engelhard VH, Thistlethwaite JR Jr, Woodle ES.

J Immunol. 1994 Aug 1;153(3):1054-67.

PMID:
7913109
14.

Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.

Newberg MH, Ridge JP, Vining DR, Salter RD, Engelhard VH.

J Immunol. 1992 Jul 1;149(1):136-42.

PMID:
1607650

Supplemental Content

Loading ...
Support Center